United States Department of Health and Human Services (HHS)
Issuing Organization
National Center for Injury Prevention and Control, Center for Disease Control and Prevention (NCIPC/CDC), at http://www.cdc.gov/ncipc/
Participating Organizations Center for Disease Control and Prevention (CDC), at http://www.cdc.gov/
National Center for Injury Prevention and Control (NCIPC/CDC), at http://www.cdc.gov/ncipc/
Title:
Dissertation Grant Awards for Doctoral Candidates for Violence-Related Injury Prevention Research in Minority Communities (K01)
Announcement Type:
NewInstructions for Submission of Electronic Research Applications:
NOTICE:
Applications submitted in response to this Funding Opportunity Announcement (FOA) for Federal assistance must be submitted electronically through Grants.gov http://www.grants.gov using the SF424 Research and Related (R&R) forms and the SF424 (R&R) Application Guide.If you do not have access to the Internet, or if you have difficulty accessing the forms online, you may contact the CDC Procurement and Grants Office Technical Information Management Section (PGOTIMS) staff. For this, or further assistance, contact PGO TIMS: Telephone (770) 488-2700, Email: PGOTIM@cdc.gov.
This FOA must be read in conjunction with the application package instructions included with this announcement on Grants.gov/Apply for Grants (hereafter referred to as, Grants.gov/Apply.)
A registration process is necessary before submission, and applicants are highly encouraged to start the process at least four weeks prior to the grant submission date. See Section IV.
Required for on-time submission:
1) The application must be successfully received by Grants.gov no later than 5:00 p.m. Eastern Standard Time on the application submission receipt date (see "Key Dates" below.)
Note: CDC also encourages all applicants to register in the Electronic Research Administration (eRA Commons) Although an eRA Commons account is not mandatory for applications in response to this FOA, future FOAs may require your participation in eRA Commons to complete an electronic application submission through Grants.gov. Please visit:
NIH eRA Commons to learn more about the features of eRA Commons and begin your registration process as early as possible.Funding Opportunity Announcement (FOA) Number:
CDC-RFA-CE07-009Catalog of Federal Domestic Assistance Number(s):
93.136, Injury Prevention and Control Research and State and Community Based ProgramsKey Dates
Release/Posted Date: October 6, 2006Additional Information to Be Available Date (URL Activation Date): November 8, 2006
Technical assistance will be available for potential applicants during one conference call. The call for eligible applicants will be held on November 8, 2006 from 1:30 p.m. to 3:30 p. m. (Eastern Time). The conference can be accessed by calling 1-866-662-4806,
entering the passcode: 5488061, and stating the leader name: MS LADY PATTERSON.
Due Date for E.O.
12372
Executive Order 12372 does not apply to this program.
Additional Overview Content
Executive Summary
NCIPC is soliciting investigator initiated and mentored research scientist development award (K01) applications from doctoral students that will help expand and advance our understanding of violence, its causes, and prevention strategies in minority communities.
The proposed research must address one of the research priorities listed in the following chapters from NCIPC’s research agenda; Preventing Intimate Partner Violence, Sexual Violence, and Child Maltreatment, Preventing Suicidal Behavior, or Preventing Youth Violence.
The study population must be an ethnic minority. http://www.whitehouse.gov/omb/fedreg/1997standards.html
The participating organizations intend to commit a total of $100,000 to this RFA/PAR for payment of applications responsive to this announcement statement.
Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.
Three to four awards will be funded
Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the activity code, quality, duration, and costs of the applications received.
Budget Period, Project Period, and Award Amounts: The budget period is one year, the project period is one year, and the award amount will not exceed $25,000 total (including direct and indirect costs).
Eligible Organizations
: universities and collegesEligible Project Directors/Principal Investigators (PD/PIs): Doctoral students from any United States public or private college or university may submit an application. The institution must support an accredited doctoral level training program. The performance site must be domestic. To be eligible for this FOA, the principal investigator must be a student in good standing enrolled in an accredited doctoral degree program. The principal investigator must have a mentor for the proposed research. Normally the mentor is the chair (or a member) of the applicant’s dissertation committee.
The applicant must have prior or existing experience working with the defined community. The investigator must define the relevant community or population for their study using a set of criteria that defines their risk to being disproportionately impacted by violence such as; identity, characteristic, or condition. A letter(s) of support should be included in the application.
Principal investigators can only submit one grant application in response to this FOA.
See Section IV.1 for application materials. The SF424 (R&R) Application Guide for this FOA is located at these Web sites: Grants.gov Application Guide SF424 (R&R) - MS Word ; or Grants.gov Application Guide SF424 (R&R) - PDF
For general information on SF424 (R&R) Application and Electronic Submission, see the following Web sites: SF424 (R&R) Application and Electronic Submission Information ;and General Information on Electronic Submission of Grant Applications
HHS/CDC Telecommunications for the hearing impaired is available at the following number: TTY 770-488-2783.
Funding Opportunity Announcement Glossary:
FOA Glossary TerminologyTable of Contents
Part I Overview Information
Part II Full Text of Announcement
Section I. Funding Opportunity Description
1. Research Objectives
Section II. Award Information
1. Mechanism(s) of Support
2. Funds Available
Section III. Eligibility Information
1. Eligible Applicants
A. Eligible Institutions
B. Eligible Individuals
2. Cost Sharing or Matching
3. Other - Special Eligibility Criteria
Section IV. Application and Submission Information
1. Request Application Information
2. Content and Form of Application Submission
3. Submission Dates and Times
A. Receipt and Review and Anticipated Start
Dates
1. Letter of Intent
B. Sending an Application to CDC
C. Application Processing
4. Intergovernmental Review
5. Funding Restrictions
6. Other Submission Requirements
Section V. Application Review Information
1. Criteria
2. Review and Selection Process
A. Additional Review Criteria
B. Additional Review Considerations
C. Sharing Research Data
D. Sharing Research Resources
3. Anticipated Announcement and Award Dates
Section VI. Award Administration Information
1. Award Notices
2. Administrative and National Policy Requirements
3. Reporting
Section VII. Agency Contact(s)
1. Scientific/Research Contact(s)
2. Peer Review Contact(s)
3. Financial/ Grants Management Contact(s)
4. General Questions Contact(s)
Section VIII. Other Information - Required Federal Citations
Section I. Funding Opportunity Description
1. Research Objectives
The National Center for Injury Prevention and Control (NCIPC) of CDC within HHS is committed to achieving the health promotion and disease prevention objectives of "Healthy People 2010" and to measuring program performance as stipulated by the Government Performance and Review Act (GPRA). This FOA addresses "Healthy People 2010" priority area(s) of injury and violence prevention and is in alignment with NCIPC performance goal(s) to conduct a targeted program of research to reduce injury related death and disability.
For more information, see http://www.healthypeople.gov/ and http://www.whitehouse.gov/omb/mgmt-gpra/
Background
A dissertation represents the most extensive research experience formulated and carried out by a doctoral candidate, with the advice and guidance of a mentor (the chair or another member of the dissertation committee). Dissertation research involves a major investment of the doctoral student's time, energy, and interest and its substance is often the basis for launching a research career. This research initiative is aimed at providing students with assistance to complete their dissertation research on a violence-related topic and, thereby, increasing representation of junior investigators in violence-related injury research.
Deaths and injuries associated with interpersonal violence and suicidal behavior are a major public health problem in the United States and around the world. In 2002, more than 49,000 people died from homicide and suicide in the United States. Among 15 to 24 year olds, homicide and suicide ranked as the second and the third leading causes of death, respectively. Violent deaths are the most visible consequence of violent behavior in our society. Morbidity associated with physical and emotional injuries and disabilities resulting from violence, however, also constitute an enormous public health problem. For every homicide that occurs each year there are more than 100 non-fatal injuries resulting from interpersonal violence. For every completed suicide it is estimated that there are 20 to 25 suicide attempts. The mortality and morbidity associated with violence are associated with a variety of types of violence including child mistreatment, youth violence, intimate partner violence, sexual violence, elder abuse, and self-directed violence or suicidal behavior.
Violence has a disproportionate impact on racial and ethnic minorities. In 2002, homicide was the leading cause of death for African Americans and the second leading cause of death for Hispanics between the ages of 15 and 34. Suicide was the second leading cause of death for American Indians and Alaskan Natives and Asian and Pacific islanders 15 to 34 years of age. It is important to note that existing research indicates that race or ethnicity, per se, is not a risk factor for violent victimization or a cause of violent behavior. Rather, racial or ethnic status is associated with many other factors that do influence the risk of becoming a victim or behaving violently. Nevertheless, racial and ethnic minorities in the United States are at high risk for both violent victimization and perpetration. A better understanding of the factors that contribute to this vulnerability or protection from such risk is important to furthering effective violence prevention programs that address racial and ethnic minorities.
There is a critical need for highly qualified scientists to carry out research on violence that can help in the development, implementation, and evaluation of effective violence prevention programs. In particular, scientists are needed who bring an understanding and sensitivity to the problems of violence as they affect minority communities. The purpose of this extramural research training grant program is to attract young scientists to the field of violence prevention by encouraging doctoral candidates from a variety of disciplines to conduct violence prevention research and hopefully carry this focus on throughout their careers. The number of individuals who are members of minority groups and who are engaged in violence-related injury prevention research is currently small. This research program should also attract young minority scientists to the field of violence research.
Purpose
The purposes of this FOA are to:
• Solicit research applications that address the priorities reflected under the heading, "Research Objectives".
• Build the scientific base for the prevention and control of injuries, disabilities, and deaths disproportionately experienced in minority communities. http://www.whitehouse.gov/omb/fedreg/1997standards.html
• Encourage doctoral candidates from a wide spectrum of disciplines, including epidemiology, medicine, biostatistics, health economics, public health, law and criminal justice, behavioral, and social sciences to perform research in order to prevent and control injuries more effectively.
• Assist students in the completion of their dissertation research on a violence-related injury topic.
• Encourage investigators to build research careers related to the prevention of violence-related injuries, disabilities, and deaths in minority communities.
Research Objectives
NCIPC is soliciting investigator-initiated research that will help expand and advance our understanding of violence, its causes, and prevention strategies in minority communities. Applicants are encouraged to propose studies that can feasibly be completed within the available funds and funding period.
For this FOA, the proposed research must address one of the research priorities listed in the following chapters from NCIPC’s research agenda: Preventing Intimate Partner Violence, Sexual Violence, and Child Maltreatment, Preventing Suicidal Behavior, or Preventing Youth Violence. NCIPC’s research agenda can be accessed online at the following address: http://www.cdc.gov/ncipc/pub-res/research_agenda/agenda.htm
In addition, the proposed research must address the research priority as it pertains to a minority community.
Special Considerations
• Proposed research must address one of the research priorities as it applies to a minority community.
• Applications are encouraged from organizations that serve predominantly racial and ethnic minority populations that are disproportionately affected by violence. . http://www.whitehouse.gov/omb/fedreg/1997standards.html
• Funding priority will be given to projects that demonstrate strong community partnerships and access to predominantly Black and Hispanic communities that are disproportionately affected by the violence.
• The applicant must have prior or existing experience working with the defined community. The investigator must define the relevant community or population for their study using a set of criteria that defines their risk to being disproportionately impacted by violence such as; identity, characteristic, or condition. A letter(s) of support should be included in the application. Applicants whose research will bring an understanding and sensitivity to the problems of violence in affected underrepresented, minority communities are encouraged to apply.
• If an FOA is developed and published, NCIPC scientists will initiate a conference call to assist potential applicants.
• If an FOA is developed and published and grants/cooperative agreements are awarded, there should be an annual progress meeting between grantees and NCIPC scientists, therefore travel money must be budgeted.
See Section VIII, Other Information - Required Federal Citations, for policies related to this announcement.
Section II. Award Information
1. Mechanism(s) of Support
This funding opportunity is a mentored research scientist development (K01) research grant and will use the
K01 activity code.This FOA uses just-in-time concepts. It also uses the non-modular budget format described in the SF424 Research and Related (R&R) Budget Component application instructions see http://grants.nih.gov/grants/funding/424/index.htm/ A detailed categorical budget for the "Initial Budget Period" and the "Entire Proposed Period of Support" must be submitted with the application.
2. Funds AvailableThe participating Centers, Institutes, and Offices (CIO)(s) (NCIPC) intend to commit approximately $100,000 (direct plus indirect) dollars in FY2007 to fund 4 applications. The average award amount will be $25,000 total (direct plus indirect)
for the12-month budget period. An applicant may request a project period of up to one year. An applicant may request up to $25,000 maximum for the12-month budget period. The approximate total project period funded amount is $25,000. The anticipated start date for new awards is September, 2007.All estimated funding amounts are subject to availability of funds.
If an applicant requests a funding amount greater than the ceiling of the award range, HHS/CDC will consider the application non-responsive, and it will not enter into the review process. HHS/CDC will notify the applicant that the application did not meet the submission requirements.
Facilities and Administrative (F&A) costs requested by
consortium participants are included in the direct cost
limitation. See NOT-OD-05-004.
This FOA is a one-time solicitation.
1. Eligible
Applicants
1.A. Eligible Institutions
You may submit (an) application(s) if your organization has any of the following characteristics:
·
Universities·
CollegesThe institution must be in the United States and must support an accredited doctoral level training program. Foreign organizations are not eligible for this FOA. Funding is limited to doctoral students at universities and colleges in order to support researcher training to increase the population of violence researchers. By definition, a doctoral research student must be enrolled in a university or college that offers this type of training
Any individual with the skills, knowledge, and resources necessary to carry out the proposed research as the Project Director/Principal Investigator (PD/PD) is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for CDC programs. To be eligible for this FOA, the principal investigator must be a student in good standing enrolled in an accredited doctoral degree program. The doctoral candidate must be the designated principal investigator and must be responsible for planning, directing, and executing the proposed project with the advice and consultation of the mentor and dissertation committee. The applicant must have the skill and academic training to conduct the proposed research and have the authority and responsibility to carry out the proposed project. To receive this funding, applicant must have successfully defended their dissertation proposal.
The principal investigator must have a mentor for the proposed research. Normally the mentor is the chair (or a member) of the applicant’s dissertation committee. List the mentor under "Key Personnel" in the SF424 form and include a biosketch for the mentor in the application.
Applications are encouraged from individuals employed by organizations that serve predominantly racial and ethnic minority populations that are disproportionately affected by violence.
Funding priority will be given to projects that demonstrate strong community partnerships and have a history of service or access to predominantly minority communities that are disproportionately affected by the violence.
2. Cost Sharing or Matching
Grant applications must demonstrate a match between the applicant's proposed research and the program priorities as described under the heading, "Research Objectives." In the "Research Plan" section of their application the applicant must indicate which priority from NCIPC’s research agenda http://www.cdc.gov/ncipc/pub-res/research_agenda/agenda.htm is being addressed and how their proposed research will address that priority. They must also describe how they will address this priority in a minority community.
Evidence that the principal investigator is a doctoral student in good standing enrolled in an accredited doctoral degree program must be documented by providing a copy of applicant’s graduate school transcript and a letter from the applicant's mentor. Place these items in the appendix of your application.
Applications must demonstrate effective and well defined working relationships within the performing organization and with outside entities which will ensure implementation of the proposed activities, as evidenced by letters of support from all relevant participating organizations. Place these letters in the appendix of your application.
Principal investigators can submit only one grant application in response to this FOA. Only one application per principal investigator will be funded under this announcement.
If your application is incomplete or non-responsive to the special requirements listed in this section, it will not enter into the review process
Note: Title 2 of the United States Code Section 1611 states that an organization described in Section 501(c)(4) of the Internal Revenue Code that engages in lobbying activities is not eligible to receive Federal funds constituting an award, grant, or loan.
Section IV. Application and Submission Information
To download a SF424 (R&R) Application Package and SF424 (R&R) Application Instructions for completing the SF424 (R&R) forms for this FOA, link to http://www.grants.gov/Apply/ and follow the directions provided on that Web site.
A one-time registration is required for institutions/organizations at the following:
Grants.gov at http://www.grants.gov/GetStarted
Note: eRA Commons, CDC strongly encourages all applicants (both Organizations and Project Directors/Principal Investigators [PD/PI]) to also register in Electronic Research Administration (eRA http://era.nih.gov/ElectronicReceipt/preparing.htmCommons as soon as possible (see below). Although an eRA Commons account is not mandatory at this time, future FOAs may require your participation in eRA Commons to complete an electronic application submission through Grants.gov. Important information on registration can be obtained at the following:
eRA Commons Registration, Electronic Submission of Grant Applications
PD/PIs should work with their institutions/organizations to make sure they are registered in the eRA Commons as early as possible.
Applicant institutions/organizations should complete the following actions as soon as possible:
1) Organizational/Institutional Registration in Grants.gov/ Get StartedRegistered.
·
Your organization will need to obtain a Data Universal Number System (DUNS) number and register with the Central Contractor Registration (CCR) as part of the Grants.gov registration process.·
If your organization does not have a Taxpayer Identification Number (TIN) or Employer Identification Number (EIN), allow for extra time. A valid TIN or EIN is necessary for CCR registration.·
The CCR also validates the EIN against Internal Revenue Service records, a step that will take an additional one to two business days.·
Direct questions regarding Grants.gov registration to:2) Organizational/Institutional Registration in the eRA Commons
To find out if an organization is already eRA Commons-registered, see the "List of Grantee Organizations Registered in eRA Commons."
·
Direct questions regarding the eRA Commons registration to:3) Project Director/Principal Investigator (PD/PI) Registration in the eRA Commons: Refer to the NIH eRA Commons System (COM) Users Guide.
·
The individual designated as the PD/PI on the application must also be registered in the eRA Commons. It is not necessary for PDs/PIs to register with Grants.gov.·
The PD/PI must hold a PD/PI account in the eRA Commons and must be affiliated with the applicant organization. This account cannot have any other role attached to it other than the PD/PI.·
This registration/affiliation must be done by the Authorized Organization RepresentatieRepresentative/Signing Official (AOR/SO) or their designee who is already registered in the eRA Commons.·
Both the PD/PI and AOR/SO need separate accounts in the eRA Commons since both hold different roles for authorization and to view the application process.Note that if a PD/PI is also an HHS peer-reviewer with an Individual DUNS and CCR registration, that particular DUNS number and CCR registration are for the individual reviewer only. These are different than any DUNS number and CCR registration used by an applicant organization. Individual DUNS and CCR registration should be used only for the purposes of personal reimbursement and should not be used on any grant applications submitted to the Federal Government.
Several of the steps of the registration process could take four weeks or more. Therefore, applicants should immediately check with their business official to determine whether their organization/institution is already registered in both Grants.gov and the eRA Commons.Commons. The HHS/CDC strongly encourages applicants to use the Grants.gov electronic applications process and have organizations and PD/PIs complete all necessary registrations.
1. Request Application Information
Note: Only the forms package directly attached to a specific FOA can be used. You will not be able to use any other SF424 (R&R) forms (e.g., sample forms, forms from another FOA), although some of the "Attachment" files may be useable for more than one FOA.
If you do not have access to the Internet, or if you have difficulty accessing the forms online, you may contact the CDC Procurement and Grants Office Technical Information Management Section (PGOTIMS) staff. For this, or further assistance, contact PGO TIMS: Telephone (770) 488-2700, Email: PGOTIM@cdc.gov.
HHS/CDC Telecommunications for the hearing impaired: TTY
770-488-2783.
Prepare all applications using the SF424 (R&R) application forms and in accordance with the SF424 (R&R) Application Guide (MS Word or PDF).
The SF424 (R&R) Application Guide is critical to submitting a complete and accurate application to HHS/CDC.
Do not use the Appendix to circumvent the page limitations of the research plan. In addition to letters of support, the appendix may include the following items: 1) Up to 10 publications, manuscripts (accepted for publication), abstracts, patents, or other printed materials directly relevant to this project. 2) Surveys, questionnaires, data collection instruments, clinical protocols, and informed consent documents. 3) Original glossy photographs or color images of gels, micrographs, etc., provided that a photocopy (may be reduced in size) is also included within the 15-page limit of the research plan.
Abstract (Project Summary and Relevance)
It is especially important that the abstract (Description, SF424 form page 2) of your grant application reflect the project’s focus; the abstract will be used to help determine the responsiveness of the application. The following instructions supersede those provide in the SF424 instructions. If your application is funded, your abstract will become public information.
The abstract should contain the following sections:
Importance (One or two sentences explaining the importance of the study question)
Objectives (Include specific aims and hypotheses)
Study Design
Setting
Participants (Include the number of participants and how they will be selected)
Interventions (Explain the essential features of any interventions)
Outcome Measures
The language of the abstract must be simple and easy to understand for a broad audience. For more information on how to write an abstract please see the "Structured Abstracts" section at: http://jama.ama-assn.org/ifora_current.dtl
Research Plan
For this FOA, items A-D of the Research Plan are limited to 15 pages, not 25 pages as listed in the SF424 instructions.
You must include a research plan in your application. The research plan should address activities to be conducted over the entire project period. The research plan should include the following information:
The project's focus, a justification for the research proposed, and a description of the scientific basis for the research. The focus should be based on recommendations in "Healthy People 2010" http://www.healthypeople.gov and the "CDC Injury Research Agenda," (http://www.cdc.gov/ncipc/pub-res/research_agenda/agenda.htm ) and should seek creative approaches that will contribute to a national program for injury control.
Specific, measurable, and time-framed objectives.
A detailed plan describing the methods by which the objectives will be achieved, including their sequence. A comprehensive evaluation plan is an essential component of the application.
A description of the principal investigator's role and responsibilities.
A description of those activities related to, but not supported by, the grant.
A description of the involvement of other entities, particularly minority community based organizations that will relate to the proposed project, if applicable. It should include commitments of support and a clear statement of their roles.
An explanation of how the research findings will contribute to the national effort to reduce the morbidity, mortality and disability caused by injuries within three to five years from project start-up.
The SF424 (R&R) application is comprised of data arranged in separate components. Some components are required, others are optional. The forms package associated with this FOA in Grants.gov/APPLY will include all applicable components, mandatory and optional. A completed application in response to this FOA will include the following components:
Required Components:
SF424 (R&R) (Cover component)
Research & Related Project/Performance Site Locations
Research & Related Other Project Information
Research & Related Senior/Key Person
Research & Related Budget
PHS398 Cover Page Supplement
PHS398 Research Plan
PHS398 Checklist
Optional Components:
Note: While both budget components are included in the SF424 (R&R) forms package, the CDC K01 (activity code) uses ONLY the detailed Research & Related Budget. (Do not use the PHS 398 Modular Budget.)
3. Submission Dates and Times
3. A. Submission, Review and Anticipated Start Dates
3. A.1. Letter of
Intent
Prospective applicants are asked to submit a letter of intent that includes the following information:
Descriptive title of proposed research.
Name, address, and telephone number of the Principal Investigator.
Names of other key personnel.
Participating institutions.
Number and title of this funding opportunity.
Although a letter of intent is not required, is not binding, and does not enter into the review of a subsequent application, the information that it contains allows CDC Program staff to estimate the potential review workload and plan the review.
The letter of intent is to be sent by the date listed in Section IV.3.A
The letter of intent should be sent by mail, fax or email to:
NCIPC Extramural Resources Team
CDC, National Center for Injury Prevention and Control
Address for Express Mail or Delivery Service:
2945 Flowers Rd.
Yale Building, Room 2054
Atlanta, GA 30341
Address for U.S. Postal Service Mail:
4770 Buford Hwy., NE, Mailstop K-62
Atlanta, GA 30341
Telephone: (770) 488-4037
FAX: (770) 488-1662
Email: CIPERT@cdc.gov
3. B. Submitting an Application to CDC
If the instructions in this announcement differ in any way from the 424 R&R instructions, follow the instructions in this announcement.
To submit an application in response to this FOA, applicants should access this FOA via http://www.grants.gov/Apply and follow steps 1-4. If submittal of the application is done electronically through Grants.gov http://www.grants.gov , the application will be electronically time/date stamped by Grants.gov. Applicants will receive an e-mail notice of receipt from Grants.gov when HHS/CDC receives the application.
All requested information must be received in the HHS/CDC Procurement and Grants Office by 5:00 p.m. Eastern Standard Time on the deadline date.
This announcement is the definitive guide on Letter Of Intent (LOI) and application content, submission address, and deadline. It supersedes information provided in the application instructions. If your application does not meet the deadline described in Section IV.3.A, it will not be eligible for review, and HHS/CDC will reject it. You will receive notification that you did not meet the submission requirements.
If you have a question about the receipt of your application, contact the PGO-TIMS staff at: 770-488-2700; please provide the FOA Number CE-07-009. Before calling, please wait two to three days after the submission deadline. This will allow time for HHS/CDC to process and log submissions.
3. C. Application Processing
Note that HHS/CDC will currently not be using the eRA Commons system for processing of electronic applications unless otherwise stated in the FOA. HHS/CDC encourages all applicants to get registered in eRA Commons to be able to review summary statements and review scores which can be found in eRA Commons.
Upon receipt, applications will be evaluated for completeness and responsiveness by NCIPC and HHS/CDC Procurement and Grants Office (PGO). HHS/CDC will not review incomplete and non-responsive applications.
There will be an acknowledgement of receipt of applications from Grants.gov.
The HHS/CDC will not accept any application in response to this FOA that is essentially the same as one currently pending initial review, unless the applicant withdraws the pending application. However, when a previously unfunded application, originally submitted as an investigator-initiated application, is to be submitted in response to a funding opportunity, it is to be prepared as a NEW application. That is, the application for the funding opportunity must not include an Introduction describing the changes and improvements made, and the text must not be marked to indicate the changes from the previous unfunded version of the application.
4. Intergovernmental Review
Executive Order 12372 does not apply to this program.
5. Funding Restrictions
All HHS/CDC awards are subject to the terms and conditions,
cost principles, and other considerations described in the
PHS Grants Policy Statement.
Restrictions, which applicants must take into account while writing their budgets, are as follows:
Funds relating to the conduct of research involving human subjects will be restricted until the appropriate assurances and Institutional Review Board approvals are in place.
Reimbursement of pre-award costs is not allowed.
Grant funds will not be made available to support the provision of direct care.
Eligible applicants may enter into contracts, including consortia agreements, as necessary to meet the requirements of the program and strengthen the overall application.
Allowable costs include partial salary support for the applicant, interviewer expenses, data processing, participant incentives, statistical consultant services, supplies, dissertation printing costs, and travel to one scientific meeting, if adequately justified.
Applicants must also include travel costs for a two-day trip to CDC in Atlanta to present research findings.
Indirect costs for this trainee-related grant are limited to eight percent.
No tuition support is allowed.
Because this is a research training grant, it is recommended that no salary support for the mentor be written into the budget.
If you are requesting indirect costs in your budget, you must include a copy of your indirect cost rate agreement. If your indirect cost rate is a provisional rate, the agreement should be less than 12 months of age. If submitting electronically, use a PDF version of the agreement, attach it in Grants.gov under "Other Attachments", and title it appropriately.
Applicants’ research plan(s) should address activities they will conduct over the entire project period.
Research Plan Component Sections
While each section of the Research Plan component needs to be uploaded separately as a PDF attachment, applicants are encouraged to construct the Research Plan component as a single document, separating sections into distinct PDF attachments just before uploading the files. This approach will enable applicants to better monitor formatting requirements such as page limits. All attachments must be provided to HHS/CDC in PDF format, filenames must be included with no spaces or special characters, and a .pdf extension must be used. Do not include any information in a header or footer of the attachments. A header will be system-generated that references the PD/PI. Page numbers for the footer will be system-generated in the complete application, with all pages sequentially numbered; therefore, do not number the pages of your attachments. Your research plan must not exceed 15 pages. If your research plan exceeds the page limitation, your application may be considered unresponsive and ineligible for review.
Do not to use the Appendix to circumvent the page limitations of the Research Plan component. An application that does not observe the relevant policies and procedures may not be considered in the review process. Applicants are reminded to review specific FOAs for any additional program-specific guidance on Appendix material and other application requirements.
The following materials must be included in the Appendix:
Evidence that the principal investigator is a doctoral student in good standing enrolled in an accredited doctoral degree program must be documented by providing a copy of applicant’s graduate school transcript. The applicant's graduate school transcript should show that the applicant has completed all required course work for the degree with the exception of the dissertation. This does not have to be an official copy of the transcript sent by institution’s admission office. A photocopy of the transcript is acceptable.
A letter of support from the applicant's mentor which: a. fully identifies the members of the dissertation committee, b. certifies that the mentor has read the application and believes that it reflects the work to be completed in the dissertation. (Letters certifying approval of the dissertation proposal must be received before negotiation and award of the grant.), c. certifies that the institution's facilities and general environment are adequate to conduct the proposed research.
Applications must demonstrate effective and well defined working relationships within the performing organization and with outside entities which will ensure implementation of the proposed activities, as evidenced by letters of support from all relevant participating organizations. Place these letters in the appendix of your application.
A tentative time line for completion of the research, the dissertation, and the dissertation defense.
A statement of the applicant's career goals and intended career trajectory
Plan for Sharing Research Data
All applicants must include a
plan for sharing research data in their application. The HHS/CDC
data sharing policy is available at
http://www.cdc.gov/od/pgo/funding/ARs.htm
under Additional Requirements 25 Release and Sharing of
Data. All investigators responding to this funding
opportunity should include a description of how final
research data will be shared, or explain why data sharing is
not possible.
The reasonableness of the data sharing plan or the rationale
for not sharing research data will be assessed by the
reviewers. However, reviewers will not factor the proposed
data sharing plan into the determination of scientific merit
or the priority score.
Sharing Research
Resources
Not applicable
Section V. Application Review Information
1. Criteria
Only the review criteria described below will be considered in the review process.
·
Scientific merit of the proposed project as determined by peer review·
Availability of funds·
Relevance of program priorities and the priorities of the U.S. Department of Health and Human Services2. Review and Selection Process
Applications that are complete and responsive to the FOA
will be evaluated for scientific and technical merit by an
appropriate peer review group convened by NCIPC in
accordance with the review criteria stated below.
As part of the initial merit review, all applications will:
Undergo a selection process in which only those applications deemed to have the highest scientific merit, generally the top half of applications under review, will be discussed and assigned a priority score.
Receive a written critique.
Receive a second level of review by the HHS/CDC Science and Program Review Subcommittee (SPRS) of the Secretary’s Advisory Committee for Injury Prevention and Control (ACIPC).
Applications submitted in response to this FOA will compete for available funds with all other eligible applications. The criteria listed in Section V.1. will be considered in making funding decisions.
The goals of HHS/CDC-supported research are to advance the understanding of health promotion and prevention of disease, injury, and disability, and enhance preparedness. In the written comments, evaluate the application to judge the likelihood the proposed research will have a substantial impact on the pursuit of these goals. Each of these criteria will be addressed by the reviewers and considered in assigning the overall score, weighting them and weighted as appropriate for each application.
Significance
Approach
Innovation
Investigators
Environment
Note that an application does not need to be strong in all categories to be judged likely to have major scientific impact and thus deserve a high priority score. For example, an investigator may propose to carry out important work that by its nature is not innovative but is essential to move a field forward.
2. A. Additional Review Criteria
Application Review Process
The primary review will be a peer review conducted by NCIPC Initial Review Group (IRG). Applications may be subjected to a preliminary evaluation (streamline review) by the IRG to determine if the application is of sufficient technical and scientific merit to warrant further review. NCIPC will withdraw from further consideration applications judged to be noncompetitive and promptly notify the principal investigator/program director and the official signing for the applicant organization. Those applications judged to be competitive will be further evaluated by the IRG. These applications will be reviewed for scientific merit using current NIH criteria (a scoring system of 100 - 500 points) to evaluate the methods and scientific quality of the application.
The secondary review will be conducted by the Science and Program Review Subcommittee (SPRS) of the Advisory Committee for Injury Prevention and Control (ACIPC). The ACIPC Federal agency experts will be invited to attend the secondary review and will receive modified briefing books (i.e., abstracts, strengths and weaknesses from summary statements, and project officer’s briefing materials). ACIPC Federal agency experts will be encouraged to participate in deliberations when applications address overlapping areas of research interest, so that unwarranted duplication in federally-funded research can be avoided and special subject area expertise can be shared. The NCIPC Division Associate Directors for Science (ADS) or their designees will attend the secondary review in a similar capacity as the ACIPC Federal agency experts to assure that research priorities of the announcement are understood and to provide background regarding current research activities. Only SPRS members will vote on funding recommendations, and their recommendations will be carried to the entire ACIPC for voting by the ACIPC members in closed session. If any further review is needed by the ACIPC, regarding the recommendations of the SPRS, the factors considered will be the same as those considered by the SPRS.
The ACIPC committee’s responsibility is to develop funding recommendations for the NCIPC Director based on the results of the primary review, the relevance and balance of proposed research relative to the NCIPC programs and priorities, and to assure that unwarranted duplication of federally-funded research does not occur. The secondary review committee has the latitude to recommend to the NCIPC Director, to reach over better ranked proposals in order to assure maximal impact and balance of proposed research. The factors to be considered will include:
The results of the primary review including the application’s priority score as the primary factor in the selection process.
The relevance and balance of proposed research relative to the NCIPC programs and priorities.
The significance of the proposed activities in relation to the priorities and objectives stated in "Healthy People 2010," the Institute of Medicine report, "Reducing the Burden of Injury," and the "CDC Injury Research Agenda."
Budgetary considerations.
All awards will be determined by the Director of the NCIPC based on priority scores assigned to applications by the primary review committee IRG, recommendations by the secondary review committee of the Science and Program Review Subcommittee of the ACIPC, consultation with NCIPC senior staff, and the availability of funds.
Protection of Human Subjects from Research Risk: When human subjects are involved, HHS/CDC will assess the available protections from research risk that relate to their participation in the proposed research. [see the Research Plan, Section 2, item 8 on Human Subjects in the SF424 (R&R)]
http://www.hhs.gov/ohrp/humansubjects/guidance/45cfr46.htm. Additional HHS/CDC Requirements under AR-1 Human Subjects Requirements are available on the Internet at the following address: http://www.cdc.gov/od/pgo/funding/ARs.htm.Inclusion of Women and Minorities in Research:
Does the application adequately address the HHS/CDC Policy requirements regarding the inclusion of women, ethnic, and racial groups in the proposed research? This includes: (1) The proposed plan for the inclusion of both sexes and racial and ethnic minority populations for appropriate representation; (2) The proposed justification when representation is limited or absent; (3) A statement as to whether the design of the study is adequate to measure differences when warranted; and (4) A statement as to whether the plans for recruitment and outreach for study participants include the process of establishing partnerships with community(ies) and recognition of mutual benefits (see Section 2, item 9 Inclusion or Women and Minorities of the Research Plan component of the SF424 (R&R).
Care and Use of Vertebrate Animals in Research:
If applicants plan to use vertebrate animals in the project, HHS/CDC will assess the five items described under Section 2, item 12 Vertebrate Animals of the Research Plan component of the SF424 (R&R). Additional HHS/CDC Requirements under AR-3 Animal Subjects Requirements are available on the Internet at the following address: http://www.cdc.gov/od/pgo/funding/ARs.htm
Data Sharing Plan: HHS/CDC will assess the
reasonableness of the data sharing plan. However, reviewers
will not factor the proposed data sharing plan into the
determination of scientific merit or the priority score. The
presence of a data sharing plan will be part of the terms
and conditions of the award. The funding organization will
be responsible for monitoring the data sharing policy.
Not applicable.
Grantees will be notified in August or early September of
2007 by HHS/CDC’s Procurement and Grants Office (PGO) if
their applications were selected for funding.
Section VI. Award Administration Information
1. Award Notices
HHS/CDC will contact those applicants under consideration
for funding for additional information.
A formal notification in the form of a Notice of Award (NoA) will be provided to the applicant organization. The NoA signed by the Grants Management Officer (GMO) is the authorizing document. HHS/CDC will mail and/or e-mail this document to the recipient fiscal officer identified in the application.
Selection of the application for award is not an authorization to begin performance. Any cost incurred before receipt of the NoA is at the recipient’s risk. These costs may be reimbursed only to the extent considered allowable pre-award costs. See also Section IV.5. Funding Restrictions.
The Code of Federal Regulations 45 CFR Part 74 and Part 92
have details about policy requirements. For more information
on the Code of Federal Regulations, see the National
Archives and Records Administration at the following
Internet address:
http://www.access.gpo.gov/nara/cfr/cfr-table-search.html
Additional requirements are available in Section VIII. Other
Information of this document or on the HHS/CDC website at
the following Internet address:
http://www.cdc.gov/od/pgo/funding/ARs.htm
These will be incorporated into the NoA by reference.
1. Non-Competing Grant Progress Report, (use form PHS 2590, posted on the HHS/CDC website, http://www.cdc.gov/od/pgo/funding/forms.htm and at http://grants.nih.gov/grants/funding/2590/2590.htm no less than 120 days prior to the end of the current budget period. The progress report will serve as the non-competing continuation application.
2. Financial status report, no more than 90 days after the end of the budget period.
3. Final financial and performance reports, no more than 90 days after the end of the project period.
Recipient Organization must forward these reports by the U.S. Postal Service or express delivery to the Grants Management Specialist listed in the "Agency Contacts" section of this NoA.
Although the financial plans of the HHS/CDC CIO(s) provide support for this program, awards pursuant to this funding opportunity are contingent upon the availability of funds, evidence of satisfactory progress by the recipient (as documented in required reports) and the determination that continued funding is in the best interest of the Federal government.
Section VII. Agency Contacts
HHS/CDC encourages your inquiries concerning this FOA and
welcomes the opportunity to answer questions from potential
applicants. Inquiries can fall into three areas:
scientific/research, peer review, and financial or grants
management issues:
Adele M. Childress, Ph.D, M.S.P.H
Scientific Program Administrator
National Center for Injury Prevention and Control
Centers for Disease Control and Prevention (CDC)
U.S. Department of Health and Human Services
4770 Buford Hwy NE, Mailstop K-02
Atlanta, GA 30341
Telephone: (770) 488-4233
FAX: (770) 488-4422
Email: achildress@cdc.gov
Gwendolyn Cattledge, Ph.D.
Scientific Review Administrator
National Center for Injury Prevention and Control
Centers for Disease Control and Prevention (CDC)
U.S. Department of Health and Human Services
4770 Buford Hwy NE, Mailstop K-02
Atlanta, GA 30341
Telephone: (770) 488-1430
FAX: (770) 488-4422
Email: gxc8@cdc.gov
James Masone, Grants Management Specialist
Procurement and Grants Office
Centers for Disease Control and Prevention
U.S. Department of Health and Human Services
2920 Brandywine Road
Atlanta, GA 30341
Telephone: 770-488-2736
FAX: 770-488-2670
E-mail: zft2@cdc.gov
4. General Questions Contacts:
CDC Procurement and Grants Office
U.S. Department of Health and Human Services
2920 Brandywine Road
Atlanta, GA 30341
Telephone: 770-488-2700
Email: PGOTIM@cdc.gov
Special Guidelines for Technical Assistance:
NCIPC Website:
For additional help in preparing your grant application please see the "frequently asked questions" section on the NCIPC webpage at: http://www.cdc.gov/ncipc/res-opps/2004pas.htmConference Call
Technical assistance will be available for potential applicants during one conference call. The call for eligible applicants will be held on November 8, 2006 from 1:30 p.m. to 3:30 p. m. (Eastern Time). The conference can be accessed by calling 1-866-662-4806,
entering the passcode: 5488061, and stating the leader name: MS LADY PATTERSON.Participation in this conference call is not mandatory.
At the time of the call, if you have problems accessing the conference call, please call 770-488-1044 for assistance.
Section VIII. Other Information
Required Federal Citations
Human Subjects Protection:
Federal regulations (45CFR46) require that applications and
proposals involving human subjects must be evaluated with
reference to the risks to the subjects, the adequacy of
protection against these risks, the potential benefits of
the research to the subjects and others, and the importance
of the knowledge gained or to be gained
http://www.hhs.gov/ohrp/humansubjects/guidance/45cfr46.htm
Additional HHS/CDC Requirements under AR-1 Human Subjects
Requirements can be found on the Internet at the following
address http://www.cdc.gov/od/pgo/funding/ARs.htm
Requirements for Inclusion of Women and Racial and Ethnic
Minorities in Research
It is the policy of the Centers for Disease Control and Prevention (CDC) and the Agency for Toxic Substances and Disease Registry (ATSDR) to ensure that individuals of both sexes and the various racial and ethnic groups will be included in CDC/ATSDR-supported research projects involving human subjects, whenever feasible and appropriate. Racial and ethnic groups are those defined in OMB Directive No. 15 and include American Indian or Alaska Native, Asian, Black or African American, Hispanic or Latino, Native Hawaiian or Other Pacific Islander. Applicants shall ensure that women, racial and ethnic minority populations are appropriately represented in applications for research involving human subjects. Where clear and compelling rationale exist that inclusion is inappropriate or not feasible, this situation must be explained as part of the application. This policy does not apply to research studies when the investigator cannot control the race, ethnicity, and/or sex of subjects. Further guidance to this policy is contained in the Federal Register, Vol. 60, No. 179, pages 47947-47951, and dated Friday, September 15, 1995.
INCLUSION OF PERSONS UNDER THE AGE OF 21 IN RESEARCH
The policy of CDC is that persons under the age of 21 must
be included in all human subjects research that is conducted
or supported by CDC, unless there are scientific and ethical
reasons not to include them. This policy applies to all
CDC-conducted or CDC-supported research involving human
subjects, including research that is otherwise exempt in
accordance with Sections 101(b) and 401(b) of 45 C.F.R.
Part 46, HHS Policy for the Protection of Human Subjects.
Therefore, proposals for research involving human subjects
must include a description of plans for including persons
under the age of 21. If persons under the age of 21 will be
excluded from the research, the application or proposal must
present an acceptable justification for the exclusion.
In an extramural research plan, the investigator should create a section titled "Participation of persons under the age of 21." This section should provide either a description of the plans to include persons under the age of 21 and a rationale for selecting or excluding a specific age range, or an explanation of the reason(s) for excluding persons under the age of 21 as participants in the research. When persons under the age of 21 are included, the plan must also include a description of the expertise of the investigative team for dealing with individuals at the ages included, the appropriateness of the available facilities to accommodate the included age groups, and the inclusion of a sufficient number of persons under the age of 21 to contribute to a meaningful analysis relative to the purpose of the study. Scientific review groups at CDC will assess each application as being acceptable or unacceptable in regard to the age-appropriate inclusion or exclusion of persons under the age of 21 in the research project, in addition to evaluating the plans for conducting the research in accordance with these provisions.
The inclusion of children (as defined by the applicable law of the jurisdiction in which the research will be conducted) as subjects in research must be in compliance with all applicable subparts of 45 C.F.R. Part 46, as well as with other pertinent federal laws and regulations.
The policy of inclusion of persons under the age of 21 in CDC-conducted or CDC-supported research activities in foreign countries (including collaborative activities) is the same as that for research conducted in the United States.
Paperwork Reduction Act Requirements
Under the Paperwork Reduction Act, projects that involve the collection of information from 10 or more individuals and funded by a grant or a cooperative agreement will be subject to review and approval by the Office of Management and Budget (OMB).
Smoke-Free Workplace Requirements
CDC strongly encourages all recipients to provide a smoke-free workplace and to promote abstinence from all tobacco products. Public Law 103-227, the Pro-Children Act of 1994, prohibits smoking in certain facilities that receive Federal funds in which education, library, day care, health care, or early childhood development services are provided to children.
Healthy People 2010
The Public Health Service (PHS) is committed to achieving the health promotion and disease prevention objectives of "Healthy People 2010," a PHS-led national activity for setting priority areas. This PA is related to one or more of the priority areas. Potential applicants may obtain a copy of "Healthy People 2010" at http://www.healthypeople.gov
Applicants should be aware of restrictions on the use of HHS funds for lobbying of Federal or State legislative bodies. Under the provisions of 31 U.S.C. Section 1352, recipients (and their sub-tier contractors) are prohibited from using appropriated Federal funds (other than profits from a Federal contract) for lobbying congress or any Federal agency in connection with the award of a particular contract, grant, cooperative agreement, or loan. This includes grants/cooperative agreements that, in whole or in part, involve conferences for which Federal funds cannot be used directly or indirectly to encourage participants to lobby or to instruct participants on how to lobby.
In addition no part of CDC appropriated funds, shall be used, other than for normal and recognized executive-legislative relationships, for publicity or propaganda purposes, for the preparation, distribution, or use of any kit, pamphlet, booklet, publication, radio, television, or video presentation designed to support or defeat legislation pending before the Congress or any State or local legislature, except in presentation to the Congress or any State or local legislature itself. No part of the appropriated funds shall be used to pay the salary or expenses of any grant or contract recipient, or agent acting for such recipient, related to any activity designed to influence legislation or appropriations pending before the Congress or any State or local legislature.
Any activity designed to influence action in regard to a particular piece of pending legislation would be considered "lobbying." That is lobbying for or against pending legislation, as well as indirect or "grass roots" lobbying efforts by award recipients that are directed at inducing members of the public to contact their elected representatives at the Federal or State levels to urge support of, or opposition to, pending legislative proposals is prohibited. As a matter of policy, HHS/CDC extends the prohibitions to lobbying with respect to local legislation and local legislative bodies.
The provisions are not intended to prohibit all interaction with the legislative branch, or to prohibit educational efforts pertaining to public health. Clearly there are circumstances when it is advisable and permissible to provide information to the legislative branch in order to foster implementation of prevention strategies to promote public health. However, it would not be permissible to influence, directly or indirectly, a specific piece of pending legislation
It remains permissible to use HHS/CDC funds to engage in activity to enhance prevention; collect and analyze data; publish and disseminate results of research and surveillance data; implement prevention strategies; conduct community outreach services; provide leadership and training, and foster safe and healthful environments.
Recipients of HHS/CDC grants and cooperative agreements need to be careful to prevent CDC funds from being used to influence or promote pending legislation. With respect to conferences, public events, publications, and "grassroots" activities that relate to specific legislation, recipients of HHS/CDC funds should give close attention to isolating and separating the appropriate use of HHS/CDC funds from non-CDC funds. HHS/CDC also cautions recipients of HHS/CDC funds to be careful not to give the appearance that HHS/CDC funds are being used to carry out activities in a manner that is prohibited under Federal law.
Prohibition on Use of CDC Funds for Certain Gun Control Activities
The Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act specifies that: "None of the funds made available for injury prevention and control at the Centers for Disease Control and Prevention may be used to advocate or promote gun control."
Anti-Lobbying Act requirements prohibit lobbying Congress with appropriated Federal monies. Specifically, this Act prohibits the use of Federal funds for direct or indirect communications intended or designed to influence a member of Congress with regard to specific Federal legislation. This prohibition includes the funding and assistance of public grassroots campaigns intended or designed to influence members of Congress with regard to specific legislation or appropriation by Congress.
In addition to the restrictions in the Anti-Lobbying Act, HHS/CDC interprets the language in the HHS/CDC's Appropriations Act to mean that HHS/CDC's funds may not be spent on political action or other activities designed to affect the passage of specific Federal, State, or local legislation intended to restrict or control the purchase or use of firearms.
Accounting System Requirements
The services of a certified public accountant licensed by the State Board of Accountancy or the equivalent must be retained throughout the project as a part of the recipient's staff or as a consultant to the recipient's accounting personnel. These services may include the design, implementation, and maintenance of an accounting system that will record receipts and expenditures of Federal funds in accordance with accounting principles, Federal regulations, and terms of the cooperative agreement or grant.
Capability Assessment
It may be necessary to conduct an on-site evaluation of some applicant organization's financial management capabilities prior to or immediately following the award of the grant or cooperative agreement. Independent audit statements from a Certified Public Accountant (CPA) for the preceding two fiscal years may also be required.
Proof of Non-profit Status
Proof of nonprofit status must be submitted by private nonprofit organizations with the application. Any of the following is acceptable evidence of nonprofit status: (a) a reference to the applicant organization's listing in the Internal Revenue Service's (IRS) most recent list of tax-exempt organizations described in section 501(c)(3) of the IRS Code; (b) a copy of a currently valid IRS tax exemption certificate; (c) a statement from a State taxing body, State Attorney General, or other appropriate State Official certifying that the applicant organization has a nonprofit status and that none of the net earnings accrue to any private shareholders or individuals; (d) a certified copy of the organization's certificate of incorporation or similar document that clearly establishes nonprofit status; (e) any of the above proof for a State or national parent organization and a statement signed by the parent organization that the applicant organization is a local nonprofit affiliate.
Security Clearance Requirement
All individuals who will be performing work under a grant or cooperative agreement in a HHS/CDC-owned or leased facility (on-site facility) must receive a favorable security clearance, and meet all security requirements. This means that all awardee employees, fellows, visiting researchers, interns, etc., no matter the duration of their stay at HHS/CDC must undergo a security clearance process.
Small, Minority, And Women-owned Business
It is a national policy to place a fair share of purchases with small, minority and women-owned business firms. The Department of Health and Human Services is strongly committed to the objective of this policy and encourages all recipients of its grants and cooperative agreements to take affirmative steps to ensure such fairness. In particular, recipients should:
Place small, minority, women-owned business firms on bidders mailing lists.
Solicit these firms whenever they are potential sources of supplies, equipment, construction, or services.
Where feasible, divide total requirements into smaller needs, and set delivery schedules that will encourage participation by these firms.
Use the assistance of the Minority Business Development Agency of the Department of Commerce, the Office of Small and Disadvantaged Business Utilization, DHHS, and similar state and local offices.
Research Integrity
The signature of the institution official on the face page of the application submitted under this Funding Opportunity Announcement is certifying compliance with the Department of Health and Human Services (DHHS) regulations in Title 42 Part 93, entitled PUBLIC HEALTH SERVICE POLICIES ON RESEARCH MISCONDUCT.
The regulation places requirements on institutions receiving or applying for funds under the PHS Act that are monitored by the DHHS Office of Research Integrity's (ORI) http://ori.hhs.gov./policies/statutes.shtml
For examples:
Section 93.301 Institutional assurances. (a) General policy. An institution with PHS supported biomedical or behavioral research, research training or activities related to that research or research training must provide PHS with an assurance of compliance with this part, satisfactory to the Secretary. PHS funding components may authorize [[Page 28389]] funds for biomedical and behavioral research, research training, or activities related to that research or research training only to institutions that have approved assurances and required renewals on file with ORI. (b) Institutional Assurance. The responsible institutional official must assure on behalf of the institution that the institution-- (1) Has written policies and procedures in compliance with this part for inquiring into and investigating allegations of research misconduct; and (2) Complies with its own policies and procedures and the requirements of this part.
Compliance with Executive Order 13279
Faith-based organization are eligible to receive federal financial assistance, and their applications are evaluated in the same manner and using the same criteria as those for non-faith-based organizations in accordance with Executive Order 13279, Equal Protection of the Laws for Faith-Based and Community Organizations. All applicants should, however, be aware of restrictions on the use of direct financial assistance from the Department of Health and Human Services (DHHS) for inherently religious activities. Under the provisions of Title 45, Parts 74, 87, 92 and 96, organizations that receive direct financial assistance from DHHS under any DHHS program may not engage in inherently religious activities, such as worship, religious instruction, or proselytizing as a part of the programs or services funded with direct financial assistance from DHHS. If an organization engages in such activities, it must offer them separately, in time or location, from the programs or services funded with direct DHHS assistance, and participation must be voluntary for the beneficiaries of the programs or services funded with such assistance. A religious organization that participates in the DHHS funded programs or services will retain its independence from Federal, State, and local governments, and may continue to carry out its mission, including the definition, practice, and expression of its religious beliefs, provided that it does not use direct financial assistance from DHHS to support inherently religious activities such as those activities described above. A faith-based organization may, however, use space in its facilities to provide programs or services funded with financial assistance from DHHS without removing religious art, icons, scriptures, or other religious symbols. In addition, a religious organization that receives financial assistance from DHHS retains its authority over its internal governance, and it may retain religious terms in its organization’s name, select its board members on a religious basis, and include religious references in its organization= s mission statements and other governing documents in accordance with all program requirements, statutes, and other applicable requirements governing the conduct of DHHS funded activities. For further guidance on the use of DHHS direct financial assistance see Title 45, Code of Federal Regulations, Part 87, Equal Treatment for Faith-Based Organizations, and visit the internet site:
http://www.whitehouse.gov/government/fbci/
Health Insurance Portability and Accountability Act Requirements
Recipients of this grant award should note that pursuant to the Standards for Privacy of Individually Identifiable Health Information promulgated under the Health Insurance Portability and Accountability Act (HIPAA) (45 CFR Parts 160 and 164) covered entities may disclose protected health information to public health authorities authorized by law to collect or receive such information for the purpose of preventing or controlling disease, injury, or disability, including, but not limited to, the reporting of disease, injury, vital events such as birth or death, and the conduct of public health surveillance, public health investigations, and public health interventions. The definition of a public health authority includes a person or entity acting under a grant of authority from or contract with such public agency. HHS/CDC considers this project a public health activity consistent with the Standards for Privacy of Individually Identifiable Health Information and HHS/CDC will provide successful recipients a specific grant of public health authority for the purposes of this project.
Release and Sharing of Data
The Data Release Plan is the Grantee's assurance that the dissemination of any and all data collected under the HHS/CDC data sharing agreement will be released as follows:
a. In a timely manner
b. Completely, and as accurately as possible
c. To facilitate the broader community
d. Developed in accordance with CDC policy on Releasing and Sharing Data
April 16, 2003, http://www.cdc.gov/od/foia/policies/sharing.htm and in full compliance with the 1996 Health Insurance Portability and Accountability Act (HIPPA), (where applicable), The Office of Management and Budget Circular A110, (2000) revised 2003, www.whitehouse.gov/omb/query.html?col=omb&qt=Releasing+and+Sharing+of+Data and Freedom of Information Act (FOIA) www.4.law.cornell.edu/uscode/5/5/552/html.
Applications must include a copy of the applicant's Data Release Plan. Applicants should provide HHS/CDC with appropriate documentation on the reliability of the data. Applications submitted without the required Plan may be ineligible for award. Award will be made when reviewing officials have approved an acceptable Plan. The successful applicant and the Program Manager will determine the documentation format. HHS/CDC recommends data is released in the form closest to micro data and one that will preserve confidentiality.
National Historic Preservation Act of 1966
(Public Law 89-665, 80 Stat. 915)
The grantee’s signature on the grant application attests to their: (1) knowledge of the National Historic Preservation Act of 1966 (Public Law 89-665, 80 Stat. 915); and (2) intent to ensure all grant related activities are in compliance with referenced public law, as stated:
Section 106 of the National Historic Preservation Act (NHPA) states:
The head of any Federal agency, having direct or indirect jurisdiction over a proposed Federal or Federally assisted undertaking in any State and the head of any Federal department or independent state agency having authority to license any undertaking, shall, prior to the approval of the expenditure of any Federal funds on the undertaking or prior to the issuance of any license, as the case may be, take into account the effect of the undertaking on any district, site, building, structure, or object that is included in or is eligible for inclusion in the National Register. The head of any such Federal agency shall afford the Advisory Council on Historic Preservation established under Title II of this ACT a reasonable opportunity to comment with regard to such undertaking.
Additionally, the NHPA also contains the following excerpt that forbids "anticipatory demolition:"
Each Federal agency shall ensure that the agency will not grant a loan, loan guarantee, permit, license, or other assistance to an applicant who, with intent to avoid the requirements of Section 106 of this Act, has intentionally, significantly, adversely affected a historic property to which the grant would relate or, having legal power to prevent it, allowed such significant adverse effect to occur, unless the agency, after consultation with the Council, determines that circumstances justify granting such assistance despite the adverse effect created or permitted by the applicant.
Conference Disclaimer and Use of Logos
Disclaimer: Where a conference is funded by a grant or cooperative agreement, a subgrant or a contract the recipient must include the following statement on conference materials, including promotional materials, agenda, and internet sites:
"Funding for this conference was made possible [in part] by [insert grant or cooperative agreement award number] from the Centers for Disease Control and Prevention(CDC) or the Agency for Toxic Substances and Disease Registry (ATSDR) . The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government."
Logos: Neither the HHS nor the CDC ("CDC" includes ATSDR) logo may be displayed if such display would cause confusion as to the source of the conference or give the false appearance of Government endorsement. A non-federal entity’s unauthorized use of the HHS name or logo is governed by U.S.C. § 1320b-10, which prohibits the misuse of the HHS name and emblem in written communication. The appropriate use of the HHS logo is subject to the review and approval of the Office of the Assistant Secretary for Public Affairs (OASPA). Moreover, the Office of the Inspector General has authority to impose civil monetary penalties for violations (42 C.F.R. Part 1003). Neither the HHS nor the CDC logo can be used on conference materials under a grant, cooperative agreement, contract or co-sponsorship agreement without the expressed, written consent of either the Project Officer or the Grants Management Officer. It is the responsibility of the grantee (or recipient of funds under a cooperative agreement) to request consent for the use of the logo in sufficient detail to assure a complete depiction and disclosure of all uses of the Government logos, and to assure that in all cases of the use of Government logos, the written consent of either the Project Officer or the Grants Management Officer has been received.
CDC Home Page: http://www.cdc.gov
CDC Funding Web Page: http://www.cdc.gov/od/pgo/funding/funding.htm
CDC Forms Web Page: http://www.cdc.gov/od/pgo/forminfo.htm